ChemicalBook >> CAS DataBase List >>Glasdegib

Glasdegib

CAS No.
1095173-27-5
Chemical Name:
Glasdegib
Synonyms
CS-1041;EOS-60832;Glasdegib;PF 04449913;Glasdegib-D3;Glasdegib-D4;Glasdegib-13C6;Glasdegib-13C,15N;Glasdegib USP/EP/BP;PF04449913; PF 04449913
CBNumber:
CB82658197
Molecular Formula:
C21H22N6O
Molecular Weight:
374.44
MDL Number:
MFCD25976839
MOL File:
1095173-27-5.mol
Last updated:2023-12-28 17:21:45

Glasdegib Properties

Melting point >214°C (dec.)
Boiling point 633.4±55.0 °C(Predicted)
Density 1.33±0.1 g/cm3(Predicted)
storage temp. -20°C Freezer
solubility DMSO (Slightly), Methanol (Slightly)
pka 11.93±0.10(Predicted)
form Solid
color Off-White
InChIKey SFNSLLSYNZWZQG-VQIMIIECSA-N
SMILES N([C@@H]1CCN(C)[C@@H](C2NC3=CC=CC=C3N=2)C1)C(NC1=CC=C(C#N)C=C1)=O
FDA UNII K673DMO5H9
ATC code L01XJ03

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS08
Signal word  Warning
Hazard statements  H361-H373
Precautionary statements  P201-P202-P281-P308+P313-P405-P501-P260-P314-P501

Glasdegib price More Price(23)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 9002936 PF-04449913 ≥98% 1095173-27-5 1mg $34 2024-03-01 Buy
Cayman Chemical 9002936 PF-04449913 ≥98% 1095173-27-5 5mg $109 2024-03-01 Buy
Cayman Chemical 9002936 PF-04449913 ≥98% 1095173-27-5 10mg $198 2024-03-01 Buy
Cayman Chemical 9002936 PF-04449913 1095173-27-5 25mg $412 2024-03-01 Buy
TRC G406550 Glasdegib 1095173-27-5 5mg $135 2021-12-16 Buy
Product number Packaging Price Buy
9002936 1mg $34 Buy
9002936 5mg $109 Buy
9002936 10mg $198 Buy
9002936 25mg $412 Buy
G406550 5mg $135 Buy

Glasdegib Chemical Properties,Uses,Production

Uses

Glasdegib acts as a potent, orally biovailablesmoothened (Smo) inhibitor used in the treatment of cancer.

Definition

ChEBI: Glasdegib is a member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a (2R,4S)-4-{[(4-cyanophenyl)carbamoyl]amino}-1-methylpiperidin-2-yl group at position 2. It is a hedgehog signalling pathway inhibitor that acts by binding to Smoothened (SMO) receptors and blocking signal transduction (IC50 = 5 nM). It is used in combination with low-dose cytarabine, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adult patients (aged >= 75 years), or who have medical conditions that prevent the use of standard chemotherapy. It has a role as a SMO receptor antagonist, a Hedgehog signaling pathway inhibitor and an antineoplastic agent. It is a member of benzimidazoles, a member of piperidines, a member of phenylureas and a nitrile.

Biological Activity

pf-04449913 is an orally bioavailable inhibitor of smoothened with ic50 value of 5nm [1].in the hedgehog (hh) signaling pathway, the combination of hh ligands and their receptor patched leads to the activation of smoothened and subsequently activation of three transcription factors gli1, gli2 and gli3. it then leads to the proliferation of cells. as an antagonist of smoothened, pf-04449913 is developed for treatment of cancer [1].pf-04449913 is found not to inhibit cytochrome p450 and is negative in ames and micronucleus assays suggesting it as a safe drug. in the preclinical studies, pf-04449913 shows a half-life of 30 h and an oral bioavailability of 55% in humans. it also has low plasma clearance of 1.03 ml/min/kg and moderate volume of distribution (2.7 l/kg) [1].

Biochem/physiol Actions

PF-04449913 maleate salt is also known as 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea. It increases the differentiation of blood cells from hematopoietic precursors of the lymph gland medullary zone. This human Smo inhibitor protein is now under clinical trials to treat myeloid malignancies.
PF-04449913 (Glasdegib) is an orally bioavailable Hedgehog pathway inhibitor. PF-04449913 acts by binidng Smoothened (Smo) and blocking signal transduction. PF-04449913 has an IC50 of 5 nM in the Gli-Luciferase assay. In a Phase I clinical trial in patients with advanced solid tumors, PF-04449913 caused disease stabilization in 34% of patients.

References

[1] munchhof mj, li q, shavnya a, borzillo gv, boyden tl, jones cs, lagreca sd, martinez-alsina l, patel n, pelletier k, reiter la, robbins md, tkalcevic gt. discovery of pf-04449913, a potent and orally bioavailable inhibitor of smoothened. acs med chem lett. 2011 dec 21;3(2):106-11.

50-00-0
1095173-26-4
1095173-27-5
Synthesis of Glasdegib from Formaldehyde and tert-Butyl (2R,4R)-2-[(2-aminophenyl)carbamoyl]-4-[3-(4-cyanophenyl)ureido]piperidine-1-carboxylate

Glasdegib Suppliers

Global( 123)Suppliers
Supplier Tel Email Country ProdList Advantage
Suzhou Ryan Pharmachem Technology Co.,Ltd.
+86-512-68780025 +8618962125825 sales@ryanchem.com China 137 58
Jinan Carbotang Biotech Co.,Ltd.
+8615866703830 figo.gao@foxmail.com China 7019 58
BOC Sciences
+1-631-485-4226 inquiry@bocsci.com United States 19553 58
career henan chemical co
+86-0371-86658258 15093356674; factory@coreychem.com China 29826 58
Career Henan Chemica Co
+86-0371-86658258 15093356674; laboratory@coreychem.com China 30255 58
NINGBOBENKANGJS PHARMTECHCO., LTD
+8615990591583 15990591583 CHINA 2029 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226 sales@hzclap.com CHINA 6313 58
ANHUI WITOP BIOTECH CO., LTD
+8615255079626 eric@witopchemical.com China 23556 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 28251 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471 sales@sarms4muscle.com China 10523 58

Related articles

  • How to synthesize Glasdegib?
  • Glasdegib was approved in 2018 for the treatment of newly diagnosed acute myeloid leukemia (AML) patients at least 75 years of....
  • Dec 28,2023

View Lastest Price from Glasdegib manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Glasdegib(PF-04449913) pictures 2023-05-08 Glasdegib(PF-04449913)
1095173-27-5
US $0.00-0.00 / g 100g 98% kg grade Suzhou Ryan Pharmachem Technology Co.,Ltd.
PF-04449913 (Glasdegib) pictures 2020-01-13 PF-04449913 (Glasdegib)
1095173-27-5
US $6.68 / KG 1KG 97%-99% 1kg-1000kg Career Henan Chemical Co

Glasdegib Spectrum

PF 04449913 1-((2R,4R)-2-(1H-benzo[d]iMidazol-2-yl)-1-Methylpiperidin-4-yl)-3-(4-cyanophenyl)urea N-[(2R,4R)-2-(1H-Benzimidazol-2-yl)-1-methyl-4-piperidinyl]-N'-(4-cyanophenyl)urea Glasdegib (PF-04449913) N-[(2R,4R)-2-(1H-Benzimidazol-2-yl)-1-methyl-4-piperidinyl]-N'-(4-cyanophenyl)urea PF 04449913 Glasdegib EOS-60832 CS-1041 PF-04449913 (Glasdegib) PF04449913; PF 04449913 Urea, N-[(2R,4R)-2-(1H-benzimidazol-2-yl)-1-methyl-4-piperidinyl]-N'-(4-cyanophenyl)- Glasdegib USP/EP/BP Glasdegib-13C,15N Glasdegib-13C6 Glasdegib-D3 Glasdegib-D4 1095173-27-5 Inhibitors